1.

Which of the following insulin analogue was available from 206 and marketed by Sanofi-Aventis?(a) Lispro(b) Insulin Aspart(c) Glulisine(d) GlargineI have been asked this question during an interview for a job.This key question is from Controlled Release Medication in section Controlled Release Medication of Drug Biotechnology

Answer»

The CORRECT answer is (c) Glulisine

BEST explanation: Insulin glulisine has become available in 2006. It is best known by its BRAND name Apidra and is marketed by Sanofi-Aventis. The amino ACID asparagine at position B3 is replaced by lysine and the lysine in position B29 is replaced by glutamic acid, THUS it gets its name glulisine.



Discussion

No Comment Found

Related InterviewSolutions